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Peripheral nerve injuries (PNI) resulting in a gap to be bridged between the transected nerve ends are
commonly reconstructed with autologous nerve tissue, but there is a need for valuable alternatives. This
experimental work considers the innovative use of the biomaterial Gellan Gum (GG) as a luminal ﬁller for
nerve guidance channels made from chitosan with a 5% degree of acetylation. The engineered constructs
should remodel the structural support given to regenerating axons by the so-called bands of Büngner.
Four diﬀerent GG formulations were produced by combining varying amounts of High-Acyl GG (HA-GG)
and Methacrylated GG (MA-GG). The eﬀective porosity of the freeze-dried networks was analysed by SEM
and micro-CT 3D reconstructions, while the degradation and swelling abilities were characterized in vitro
for up to 30 days. The metabolic activity and viability of immortalized Schwann cells seeded onto the
freeze-dried networks were also evaluated. Finally, the developed hydrogel formulations were freeze-
dried within the chitosan nerve guides and implanted in a 10 mm rat sciatic nerve defect. Functional and
histomorphological analyses after 3, 6, and 12 weeks in vivo revealed that although it did not result in
improved nerve regeneration, the NGC25:75 formulations could provide a basis for further development
of GG scaﬀolds as luminal ﬁllers for hollow nerve guidance channels.
1. Introduction
Peripheral nerves originate with their motor and sensory roots
from the spinal cord or the brain stem, sending eﬀerent
signals from the Central Nervous System (CNS) to all organs
and tissues, where they also collect aﬀerent information and
transmit it back to the CNS. Their widespread presence and
lack of protection against transection or injuries make them
vulnerable to diverse types of lesions, i.e. car accidents, mili-
tary and sports injuries or metabolic damage. Indeed, peri-
pheral nerve injuries (PNIs) aﬀect over one million people
across the world every year.1 Although the peripheral nervous
system (PNS) has a superior capacity to regenerate when com-
pared to the CNS, this ability is not as eﬃcient as desired and
surgical intervention is often required. However, even if skilled
microsurgical reconstruction is performed, ineﬃcient recovery
is common, leading to motor and sensory perception impair-
ments, as well as very painful conditions.2
For PNIs that require surgical intervention, like all complete
transection injuries, end-to-end suturing is applicable in the
case of gaps shorter than 5 mm. For longer gap injuries autolo-
gous nerve grafts (AUTOGs) have been considered the gold
standard for decades.3 However, they are associated with
several drawbacks, for instance, donor site morbidity and
limited availability of donor tissue. Nerve mismatches are fre-
quent, both in terms of size and alignment. Additionally, com-
plete recovery of nerve function is rare. Meanwhile, immune
rejection dismisses primary allografts and xenografts.4 Nerve
guidance conduits (NGCs), with base on the natural biology of
regeneration, seem a potentially outstanding alternative to
overcome this public health problem.1,5,6
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To date, several NGCs have been developed, using many
diﬀerent strategies, from simple hollow tubes7,8 to subdivided
or filled tubes,9,10 also comprising the addition of neuro-
trophic factors11,12 or stem cells.13,14 Also, their combinations
were explored.15
FDA approved NGCs consist of hollow tubular structures,
made from cross-linked collagen, resorbable biopolymers or
non-resorbable hydrogels.16 The absence of luminal structures
to guide axons and Schwann cells, the peripheral glia cells,
was pointed out to be one possible cause for their failure in
long gap PNIs.17,18
Chitosan is a polysaccharide extracted mainly from crab
shells and has been widely studied owing to its application in
nerve regeneration.19 Recently, Reaxon® (Medovent GmbH,
Germany), a nerve guide made from chitosan with a 5%
degree of acetylation,20 received CE and FDA approval for
reconstruction of up to 26 mm in length peripheral nerve
defects in humans. Current research eﬀorts focus on the
design of more refined chitosan nerve guides able to support
the reconstruction of nerve defects exceeding 3–5 cm in
length. Consequently, luminal enrichment should be further
engineered to optimize axonal guidance. The strategies already
explored range from simply inserting a central longitudinal
chitosan film9 to adding regenerative hydrogel matrices, like a
hyaluronic acid and laminin based hydrogel.21
Gellan Gum (GG) is a linear anionic polysaccharide com-
posed of tetrasaccharide (1,3-b-D-glucose, 1,4-b-D-glucuronic
acid, 1,4-b-D-glucose, 1,4-a-L-rhamnose) repeating units. This
biomaterial exists in nature in two forms: a high-acyl (HA-GG)
and a low-acyl (LA-GG) forms. The side groups in the LA-GG
polymeric chain are susceptible to chemical modification,
such as the incorporation of methacrylate groups (MA-GG).
The methacrylation process allows harsh reagent-free hydrogel
preparation, with temperatures and pH resembling those of
the human body.22
This experimental work proposes the utilization of diﬀerent
HA-GG and MA-GG blending hydrogels as luminal fillers of
tubular chitosan nerve guidance conduits (NGC). Since HA-GG
and MA-GG behave diﬀerently, these blends are expected to
aﬀect the hydrogel degradation rate and cellular adhesion,
thus permitting determining the influence of these parameters
on the peripheral nerve regeneration process. To our knowl-
edge, this is the first time that the biomaterial GG was studied
with regard to PNR purposes. However, GG has already shown
great potential for other regenerative applications, such as den-
tistry,23 fibrocartilage tissue engineering,24 wound healing25 or
bone regeneration,26 as well as in the area of drug delivery.27,28
After the production of diﬀerent GG formulations, the hydro-
gels were subjected to a physicochemical characterization and
in vitro preliminary assessment using immortalized Schwann
cells. Subsequently, the formulations were injected into chito-
san nerve guidance conduits, freeze-dried and implanted
in vivo for diﬀerent periods of observation time.
Immunohistochemical studies were carried out to assess nerve
regeneration and re-vascularization, allied to macroscopic
evaluation of the explants, and evaluation of functional motor
recovery and nerve morphometry. The evaluation of their
characteristics was performed in a 10 mm sciatic nerve defect
in order to select the most promising as a luminal filler for
NGCs for future studies in longer gaps.
2. Materials and methods
2.1 Production of biomedical systems
2.1.1 Production of Gellan Gum freeze-dried hydrogels.
Four diﬀerent GG-based formulations were obtained by com-
bining 0.7% (w/v) HA-GG (KelcoGelW LT100 with MW = 1–2 ×
106 Da, CP Kelco, Atlanta, GA, USA) and 0.7% (w/v) MA-GG
(Mimsys G® with MW = 62.4 kDa, Stemmatters,
Irisbiosciences,12 Guimarães, Portugal) aqueous solutions.
The studied ratios were 60 : 40%, 50 : 50%, 25 : 75%, and
0 : 100% (v/v) HA-GG : MA-GG (see Table 1). These preparations
were heated at 37 °C for 30 minutes and transferred into sili-
cone disc moulds (diameter and height were 6 mm and
10 mm, respectively) self-made from silicon tubing (purchased
from Deltalab, Spain), which were ultimately immersed in PBS
solutions (pH = 7.4) overnight. Gelation occurred by ionic
crosslinking at room temperature (RT). These hydrogels were
punched with a branched (200 μm diameter linear branches)
metallic self-made device (stainless steel) in order to create
interior linear porous channels. The obtained hydrogels were
frozen (−80 °C) and freeze-dried. The polymeric networks
obtained will be transformed into hydrogels after rehydration.
2.1.2 Production of chitosan nerve guidance conduits
(NGCs) filled with freeze-dried Gellan Gum hydrogels.
Chitosan hollow tubes, kindly supplied by Medovent GmbH
(Mainz, Germany), were manufactured under ISO 13485 con-
ditions using Medical grade chitosan (Ki2Med® LO80+
extracted from Pandalus borealis shrimp shells, MW = 260 kDa,
supplied by Altakitin S. A., Lisbon, Portugal). More specifically,
an extrusion process was applied for obtaining them, followed
by distinctive washing and hydrolysis steps to set the Degree of
Acetylation at a 5% value. The formulations were finally cut
into fragments of the required length (14 mm) and sterilized
by ethylene oxide. The mixtures mentioned in section 2.1.1.
(60 : 40%, 50 : 50% and 25 : 75% (v/v) HA-GG : MA-GG) were
injected inside the tubes with the help of a syringe. During
this step, it was important to keep 2 mm hydrogel-free seg-
ments at each extreme of the tube, for nerve insertion and
Table 1 Gellan Gum formulations and designations. This table presents
the nomenclature utilized to designate the diﬀerent formulations
studied during this experimental work
Composition
Freeze-dried
hydrogel
formulation
NGC (freeze-dried
hydrogel filling
chitosan tube)
60 : 40% (v/v) HA-GG :MA-GG H60:40 NGC60:40
50 : 50% (v/v) HA-GG :MA-GG H50:50 NGC50:50
25 : 75% (v/v) HA-GG :MA-GG H25:75 NGC25:75
0 : 100% MA-GG (v/v) HA-GG :MA-GG H0:100 x
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suture purposes. The filled tubes were then immersed in PBS
overnight for gelation by ionic crosslink, frozen at −80 °C and
freeze-dried (see Table 1).
2.2 Physicochemical characterization
2.2.1 Microstructure evaluation. The microstructure
evaluation was performed by means of observation in a
stereomicroscope, in a Scanning Electron Microscope
(SEM), and X-ray micro-computed tomography (micro-CT)
analysis. The freeze-dried HA-GG : MA-GG hydrogel formu-
lations and HA-GG : MA-GG hydrogel filled chitosan NGCs
(Table 1) were examined under the Stereo Microscope +
Lamp (Schott KL 200, model Stemi 1000, Zeiss). For SEM,
the formulations described were sputter coated with gold in
order to facilitate the analysis of their surface morphology
(model S360, Leica, Cambridge, England). The microstruc-
ture of the formulations was also qualitatively and quanti-
tatively evaluated by micro-CT analysis (n = 3). The detailed
structure of the samples was acquired by X-ray scanning
and 3D-reconstructed. Morphometric parameters, such as
porosity, mean pore size and trabecular thickness, were
determined. Data acquisition was carried out using a
SkyScan 1072 scanner with a pixel size of 2 μm and an inte-
gration time of 1182 ms. The X-ray source was set at 39.4 kV
and 244 μA. A total of 500 projections were acquired over a
rotation range of 180°, with a rotation step of 0.23°.
Datasets were reconstructed using standardized cone-beam
reconstruction software (NRecon v. 1.6.6.0, SkyScan). The
output format for each sample was bitmap images. The set
of images was orientated with DataViewer software (v. 1.4.4,
SkyScan) to obtain all the samples in the same axis. A repre-
sentative dataset of the slices was segmented into binary
images with a dynamic threshold of 40–120, which were
used for morphometric analysis (CT Analyser, v. 1.12.0.0,
SkyScan) and to obtain the 3D models (CT Vox, v. 2.3.0
r810, SkyScan).
2.2.2 Water uptake and weight loss. Water uptake and
weight loss studies concerning the GG freeze-dried hydrogels
were performed by means of PBS (pH 7.4 at 37 °C) soaking. At
predefined time points (1, 7, 14 and 30 days) swollen or
degraded samples were extracted and excess water removed
with filter paper. The water uptake ability of the formulations
was calculated according to eqn (1). To determine the degra-
dation profile over time the samples were dried at RT and
eqn (2) was applied.
Water uptake ð%Þ ¼ ðMW MIÞ=MI 100; ð1Þ
where MW is the Wet Mass (after excess water removal) and MI
is the Initial Mass.
Weight loss ð%Þ ¼ ðMIMFÞ=MI 100; ð2Þ
where MI is the Initial Mass (before immersion in solution)
and MF is the Final Mass (after drying).
Three replicates of each sample were studied and the
average values were considered.
2.3 Biological in vitro assays
Rat immortalized Schwann cells (iSCs)29 were taken from a
stock and cultured in non-coated cell culture flasks. The
culture medium was DMEM supplemented with 10% foetal
calf serum, 1% Penicillin/Streptomycin, 1% sodium pyruvate,
and 1% L-glutamine (all from PAA Laboratories GmbH).
2.3.1 Metabolic activity evaluation. iSC metabolic activity
was followed using Alamar Blue (AB), a dye that yields a fluo-
rescent signal and a colorimetric change when incubated with
metabolically-active cells. The cells were directly seeded
(500 000 cells per scaﬀold) over the GG freeze-dried hydrogels.
After 1, 5 and 7 days in vitro (DIV), a specific cell culture
medium containing 10% AB was added to the diﬀerent culture
wells. The systems were left for incubation for 3 hours, after
which the fluorescence was monitored at 590 nm emission
wavelength (excitation wavelength 530 nm) using a microplate
reader (FL 600, Bio-Tek Instruments). AB reagent was removed
using PBS and fresh culture medium was added in its place
after each AB determination. The metabolic activity values
were calculated by normalization with the mean fluorescence
value obtained for the negative controls (diﬀerent formulations
without cells that undergo the exact same processing). The
positive control refers to the same cellular density seeded on
tissue culture polystyrene (TCPs).
2.3.2 Live/dead viability assay. iSC viability was qualitat-
ively assessed using Calcein AM (for living cells) and propi-
dium iodide staining (for dead cells). The cells were seeded
(500 000 cells per scaﬀold) over the dry network formulations.
After 1, 5 and 7 days in vitro (DIV), each scaﬀold was washed
with PBS and immersed in 1 mL of culture medium sup-
plemented with 2 μg Calcein AM and 4 μg propidium iodide
(Life Technologies, CA, USA). These immersions lasted for
2 hours, after which the samples were thoroughly washed with
PBS. The samples were analyzed using a transmitted and
reflected light microscope (Axio Imager Z1m, Zeiss, Jena,
Germany).
2.4 In vivo study
2.4.1 Experimental design. The eﬀectiveness of the devel-
oped chitosan tubes filled with freeze-dried hydrogels as PNR
guidance conduits (see Table 1; NGC60:40, NGC50:50 and
NGC25:75) was tested in a 10 mm rat sciatic nerve defect.
Samples for histological analysis were collected after both
short-term (ST, 3 and 6 weeks) and long-term (LT, 12 weeks)
observation periods. For the ST studies, 4 animals were
selected for the implantation of each NGC formulation.
Hollow chitosan tubes served as positive controls.20 For LT
studies, 7 animals were studied per NGC formulation and
7 animals receiving an autologous nerve graft (AUTOG) served
as controls. The majority of the in vivo studies described in
this experimental work were performed in Hannover Medical
School (MHH, Hannover, Germany), except for the micro-CT
analysis of the explants and vascularization detection studies,
which were performed in 3B’s Research Group (Guimarães,
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Portugal). Histomorphometry was completed at University of
Turin (UNITO, Italy).
2.4.2 Surgical procedure. All animal experiments followed
the rules of the EU Directive 2010/63/EU for animal experi-
ments and were permitted by the animal care committee of
Lower-Saxony, Germany: Nds. Landesamt für Verbraucherschutz
und Lebensmittelsicherheit Dezernat 33/Tierschutz, reference
number 33.12 42502-04-12/0816.
Female Wistar rats (225 to 250 g) were kept in groups of
four animals under standard conditions (room temperature
22 ± 2 °C; humidity 55 ± 5%; light–dark cycle 14 h/10 h), with
food and water ad libitum. For surgical procedures, animals
were anesthetized by an intraperitoneal injection of chloral
hydrate (370 mg kg−1 of body weight, Sigma-Aldrich). NGCs
with a length of 14 mm were saturated for 30 minutes in 0.9%
NaCl prior to implantation. Animals were placed on a thermo-
static blanket throughout the surgical procedures and post-
operative periods. Aseptic conditions were observed.
After exposure of the sciatic nerve, it was transected at a
constant point (6 mm from the exit of the gluteus muscle) for
the removal of 5 mm of the distal end. Once the PNI was
caused, NGCs were implanted to bridge a 10 mm nerve defect.
NGCs were connected by a single 9-0 suture (9-0, EH7981G,
Ethilon, Ethicon, Scotland) to the respective nerve end.
Alternatively, autologous nerve grafts were implanted.
Therefore, a 10 mm nerve segment was excised from the same
nerve (proximal transection again at 6 mm from the exit of the
gluteus muscle), reversed and 180° turned along its longitudi-
nal axis, and sutured back into the nerve with three 9-0 sutures
at each end. Postoperative analgesia was guaranteed by intra-
muscular injection of buprenorphine (0.045 mg kg−1 of body
weight, Buprenovet®; Bayer Pharmaceuticals, Leverkusen,
Germany).
2.4.3 Evaluation of functional motor recovery.
Electrodiagnostic recordings of evoked compound muscle
action potentials (CMAPs) from the anterior tibial muscles
(TA) and the plantar muscles (PL) were performed. During the
12 week study period two sessions of non-invasive (week 4 and
week 8 post-surgery) measurements and one final session of
invasive (12 weeks post-surgery) measurements were carried
out. The investigators performing the tests were blinded for
the general implantation conditions and the formulation type
of the implanted tubes.
In brief, a portable electrodiagnostic device (Keypoint
Portable; Medtronic Functional Diagnostics A/S, Denmark) was
used to stimulate the sciatic nerve and to record the evoked
CMAPs. In the non-invasive setting, the sciatic nerve was
stimulated with single electrical pulses (100 μs duration and
supramaximal intensity) delivered by monopolar needles (30G,
diameter 0.3 mm, length 10 mm; Natus Europe GmbH,
Planegg, Germany), percutaneously placed at the sciatic notch
(proximal stimulation) or at the popliteal fossa (distal stimu-
lation). The active recording electrode was located in the
respective muscle belly, the reference electrode in the tip of
the second toe and the ground needle electrode was inserted
in the skin at the flank. In the invasive setting, the sciatic
nerves at both the injured and non-injured sides were consecu-
tively exposed. With the help of a bipolar steel hook electrode,
the sciatic nerves were directly stimulated proximal and distal
to the transplants. Single electrical pulses (100 ms duration)
with gradually increased intensity (not exceeding 8 mA) were
applied in order to evaluate the threshold and maximal CMAP.
The recording electrodes were placed as described before.
Whenever a CMAP could be evoked, the signal was recorded
and the signal amplitude of the negative CMAP peak analysed.
Amplitude ratio values were obtained using CMAP signals
evoked and recorded from the contralateral healthy side of the
animal. If no evoked CMAP was detected, a 0.00 value was
noted down.
2.4.4 Macroscopic inspection of the reconstructed nerves
upon explantation. At the end of the ST or LT observation
periods, animals were sacrificed under deep general anaesthe-
sia, following the animal protection rules. The regenerated
sciatic nerves were exposed and inspected with the help of a
microsurgery microscope.
2.4.5 Micro-CT evaluation of the explants. This technique
was performed in 3B’s Research Group (Guimarães, Portugal)
after shipment of the entire LT study (12 weeks) explants from
MHH (Hannover, Germany) which were preserved in ethanol
solutions.
The explants were scanned using a high-resolution micro-
CT device, VivaCT 80 (Scanco Medical AG, Brüttisellen,
Switzerland). 250 projections with a resolution of 1024 × 1024
pixels were obtained in each scan with an integration time of
200 ms. Images with an isotropic pixel size of 31.2 μm were
obtained at 45 kV, 177 μA and 8 W. The acquired images were
reconstructed to obtain 2D image datasets in μCT Evaluation
Program V6.5 (Scanco Medical AG, Brüttisellen, Switzerland).
Using the CT Analyser software V1.15.4.0 (Bruker micro-CT,
Belgium) the regions of interest were defined on the 2D
images of the explants that were viewed in 3D and 2D all
planes on DataViewer V1.5.3.6 (Bruker micro-CT, Belgium).
2.4.6 Nerve histology for detection of axonal regeneration
and immunological reaction‡. After the corresponding period
of study, the animals were sacrificed and the nerve implants,
together with the respective controls, were harvested for
further analysis. The entire samples were fixed in 4% PFA over-
night (4 °C), transferred to 70% ethanol and subsequently
embedded in paraﬃn.‡
For both, 6 weeks and 12 weeks time point samples, longi-
tudinal sections were produced in order to harvest the com-
plete length of the GG material and eventually regrown tissue
along the 10 mm nerve gap. As soon as the complete length of
the material was visible in one section, a series of 24 sections
(7 μm thickness) was produced and two sections per slide were
collected. Again, the sections on one slide were harvested at
‡During the ST study, explanted samples were, immediately after explantation
and macroscopic evaluation, processed for histology. In contrast, samples
obtained after the LT observation period were sent back from 3B’s Research
Group (Guimarães, Portugal) to MHH (Hannover, Germany) after micro-CT scan-
ning in order to have them processed for histology.
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84 μm distance from each other. Once the first section series
was completed a similar one, the second one, was collected
without discarding any tissue. In the end, a total distance of
336 μm was longitudinally cut from the middle of the NGC
content.
Selected slides were subjected to haematoxylin–eosin (HE)
staining. Briefly, samples were deparaﬃnised in xylol, hydrated
through decreasing ethanol series (100%, 96%, 70% and 50%
alcohol) and finally washed in distilled water. After immersion
in haematoxylin, samples were rinsed in running soft tap
water. Samples were then immersed in an 80% alcohol solu-
tion and briefly in the eosin staining. Slides were dehydrated
through 96% ethanol, absolute ethanol and finally cleared in
xylol and mounted with Moviol (Calbiochem, Germany, No.
475904).
Immunohistology was performed over sections that were
consecutive to the ones processed for HE staining. A double-
staining was performed to detect neurofilaments (NF-200) and
activated macrophages (ED-1). Nuclear counterstaining was
obtained with DAPI. For such, slides were deparaﬃnised and
immersed in an antigen retrieval solution (citrate buﬀer,
10 mM, pH 6.0 + 0.05% Tween 20), heated at 90 °C for
30 minutes and left to cool down for another 30 minutes in
distilled water. Afterwards, they were incubated in a blocking
solution (PBS + 5% milk powder + 0.5% Triton X-100) prior to
incubation with a primary mouse anti-rat ED-1 antibody
(1 : 1000 diluted in blocking solution, MCA 275R Serotec, UK)
at 4 °C overnight. The next day the sections were washed with
PBS (3×) before being incubated with an Alexa 555-conjugated
secondary goat-anti-mouse antibody (1 : 1000 diluted in block-
ing solution, Invitrogen, Germany) for 1 hour at room tempera-
ture (RT). After incubation with the secondary antibody, sec-
tions were further washed with PBS (3×) and a second blocking
step was performed for 20 minutes.
Overnight incubation (4 °C) with a primary rabbit anti-rat
NF-200 antibody (1 : 200 diluted in blocking solution, N4142,
Sigma Aldrich, Germany) was done following the previously
described steps. The samples were washed with PBS (3×) and
incubated with an Alexa 488-conjugated secondary goat-anti
rabbit antibody (1 : 1000 diluted in blocking solution,
Invitrogen, Germany) for 1 hour at RT. The double-labelled
sections were afterwards counterstained with the nuclear dye
(DAPI, 1 : 2000 diluted in PBS, Sigma, Germany) for 5 minutes
at RT, and finally mounted with Moviol.
For the qualitative analysis, representative photomicro-
graphs of HE stained sections were taken with the help of
BX53 and BX51 microscopes, as well as analysed with the help
of the programs CellSense Dimension and CellSense Entry (all
from Olympus, Germany). Immunohistochemistry images
were digitized by means of a fluorescence microscope (BX60,
Olympus, Germany), operated by using cellP software
(Olympus, Germany) and also qualitatively analysed.
2.4.7 Nerve histology for the detection of neovasculariza-
tion‡. Immunohistology for neovascularization (CD31 and
CD34) was performed in 3B’s Research Group (Guimarães,
Portugal), after shipment of paraﬃnised slides. Slide sections
consecutive to the ones processed for HE and double immuno-
staining staining were used for this purpose. Blind-coded sec-
tions from each segment were deparaﬃnised and immersed in
an antigen retrieval solution (citrate buﬀer, 10 mM, pH 6.0 +
0.05% Tween 20), heated at 90 °C for 30 minutes and left to
cool down for another 30 minutes in distilled water. Slides
were posteriorly immersed in a blocking solution (PBS + 3%
BSA) prior to incubation with a primary goat anti-Mouse/Rat
CD31/PECAM-1 antibody (AF3628, R&D Systems, UK) (15
μg ml−1 diluted in PBS + 1% BSA) at 4 °C overnight. The next
day the corresponding sections were washed with PBS (3×)
before being incubated with an Alexa 488-conjugated second-
ary rabbit anti-goat antibody (1 : 500 in PBS + 1% BSA) for
1 hour at RT. After incubation with the secondary antibody,
sections were further washed with PBS (3×) and a second
blocking step was done for 20 minutes. This was followed by
overnight incubation (4 °C) with a primary rabbit anti-mouse
CD34 antibody (1 : 2500 diluted in PBS + 1% BSA, Abcam,
Cambridge, UK). After washing with PBS (3×), incubation with
an Alexa Fluor 594 donkey anti-rabbit IgG secondary antibody
(1 : 500 diluted in PBS + 1% BSA, Molecular Probes, Oregon,
United States) was performed for 1 hour at RT. Sections were
finally counterstained with the nuclear dye (DAPI, 1 : 2000
diluted in PBS, Sigma, Germany) for 5 minutes at RT and then
mounted with PermaFluor (Thermo Fisher Scientific, UK).
Since for the 3 weeks’ time point the samples were cut into
cross-sections, the example photo belongs to an area around
5 mm after the proximal nerve end. Results were qualitatively
analysed using a transmitted and reflected light microscope
(Axio Imager Z1m, Zeiss, Jena, Germany).
2.4.8 Nerve morphometry. In the LT study, upon explanta-
tion 12 weeks after nerve reconstruction, nerve tissue segments
5 mm in length were harvested directly distal to the sutures
connecting the implants with the distal nerve end and pro-
cessed for nerve morphometry. Segments taken from the con-
tralateral healthy nerve at a similar height served as controls.
Therefore, fixation was performed in Karnovsky fixans (2%
PFA, 2.5% glutaraldehyde in 0.2 M sodium cacodylate buﬀer,
pH 7.3, for 24 h)30,31 prior to rinsing the samples 3 times with
0.1 M sodium cacodylate buﬀer containing 7.5% sucrose. Post-
fixation was performed in 1% OsO4 for 1.5 hours followed by
myelin staining for 24 h in 1% potassium dichromate,
24 hours in 25% ethanol and 24 h in hematoxilin (0.5% in
70% ethanol), according to a modified Schultze protocol.32
After dehydration, the samples were embedded in EPON
(SERVA Electrophoresis GmbH, Heidelberg, Germany). Semi-
thin (1 μm) cross-sections were cut with glass knives
(Ultramikrotome System, 2128 Ultrotome®, LKB, Bromma,
Sweden) and mounted on uncoated glass slides. Toluidine
blue staining was then performed to further enhance the
myelin staining.33 For quantitative analysis, those samples
were chosen that were obtained from animals with electrodiag-
nostically proved reinnervation of the tibialis anterior muscle
12 weeks after surgery (LT). Morphometric analysis revealed
the total number of myelinated fibers, cross sectional area,
nerve fiber density, axon diameter, fiber diameter, g-ratio, and
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myelin thickness. All histomorphometry was performed with
the help of systematic random sampling20 at the University of
Turin (UNITO, Italy) after shipping the finalized slides/sections
from MHH.
2.5 Statistical analysis
All quantitative physicochemical and biological in vitro experi-
ments were run in triplicates, and the results are expressed as
the mean ± standard deviation. Statistical analysis of the data
was conducted using GraphPad Prism Software for Windows,
version 5.00 (GraphPad Software, Inc., La Jolla, USA).
Regarding the Alamar Blue assay, normality of the data distri-
bution was tested by using the Shapiro–Wilk normality test.
Afterwards, a Kruskal–Wallis test was performed in order to
compare the diﬀerent groups, followed by Dunn’s multiple
comparison test. The significance level was set at *p < 0.05,
**p < 0.01, and ***p < 0.001.
No statistical analysis was performed on the data obtained
during functional evaluation of nerve recovery since n ≤ 3 of
the NGC groups demonstrated functional recovery and the
numbers were too few for statistical analysis. The results of the
morphometric analysis are given in terms of the mean ± SD
for healthy nerve samples, AUTOG and NGC25:75, while for
less than 3 animals per group (NGC50:50) the single values are
presented. *p < 0.05 after Dunn’s multiple comparison test.
3. Results
3.1. Physicochemical characterization
3.1.1 Microstructure evaluation. All GG freeze-dried hydro-
gels (H60:40, H50:50, H25:75, H0:100, Table 1) were analysed
according to the techniques mentioned above. However, due
to the similar aspects of the diﬀerent formulations, only the
images corresponding to formulation H25:75 are presented.
In Fig. 1, the first row of images shows the diﬀerent repre-
sentative aspects displayed by GG formulations along the
preparation process. Fig. 1A presents an outline of the network
with the intended microstructure. Fig. 1B shows the hydrogels
obtained after the ionic PBS cross-linking. These hydrogels
were punched with branched wires (Fig. 1C) to produce vertical
aligned porous channels within their structure. Fig. 1D shows
the aspects of the freeze-dried networks obtained. Once rehy-
drated with cell culture medium, the formulations become
hydrogels that maintain the conferred porous structure
(Fig. 1E). Fig. 1F shows the SEM microphotographs corres-
ponding to the surfaces of the cross-sections. High diameter
pores (around 200 μm) can be seen, which originate from
both, metallic punching and freeze-drying. Meanwhile, Fig. 1G
presents the longitudinal cut of a scaﬀold. The aligned chan-
nels made by the metallic device (indicated by arrows) are
clearly discernible from the random pores obtained by freeze-
drying. Fig. 1H and I show the longitudinal and transversal
sections, respectively, of the chitosan tubes (arrows pointing to
their walls) filled with the GG freeze-dried hydrogels.
Micro-CT studies were performed to obtain 3D reconstruc-
tions of the studied formulations at the micrometric level.
Fig. 1J and K show the 3D reconstructed structures of the
freeze-dried GG hydrogels and the final NGC constructs,
respectively.
Micro-computed tomography technology was also used to
define the mean pore size (μm), the mean trabecular thickness
(μm) and the % of porosity of all developed formulations.
Regarding the freeze-dried GG formulations, detailed results
can be found in the supplementary material supplied (ESI
Table S1†). The mean pore size varied from 230.6 ± 3.2 to
339.0 ± 75.9 μm, trabecular thickness from 58.1 ± 2.1 to 65.8 ±
4.7 μm and the % of porosity from 79.2 ± 1.7 to 81.5 ± 8.2%.
For hydrogels freeze-dried within NGCs (ESI Table S2†) the
Fig. 1 Macro- and microstructure evaluation of the developed formu-
lations. The ﬁrst row of images corresponds to the diﬀerent aspects of
the formulations throughout the production process: (A) scheme of a
scaﬀold with the intended microstructure of vertically aligned channels;
(B) hydrogels obtained after the ionic PBS cross-linking; (C) hydrogels
punched with branched wires to display longitudinal porous channels;
(D) freeze-dried hydrogels; (E) rehydrated freeze-dried hydrogels resem-
bling the initial scheme. The second row of images corresponds to SEM
micrographs of the freeze-dried formulations: (F) surface cross-section
of the scaﬀold; (G) longitudinal cut of the scaﬀold. White arrows point
to the aligned channels made by the punching (right), which diﬀer from
the random network porosity (left); (H) longitudinal section of a chitosan
NGC (arrows pointing to the wall of it) ﬁlled with GG freeze-dried hydro-
gels and (I) cross-section of the chitosan NGC (arrows pointing to its
wall) ﬁlled with GG freeze-dried hydrogels. The third row of images
reveals the structure of the biomaterials after micro-CT 3D reconstruc-
tions: (J) 3D reconstructions of freeze-dried GG networks; (K) 3D recon-
structions of ﬁnal NGC constructs. As the aspects of all the studied for-
mulations are very similar, the previously presented images are repre-
sentative of all of them. Scale bars: 1 mm.
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mean pore sizes varied from 321.6 ± 89.4 to 377.8 ± 50.8 μm,
trabecular thickness from 98.0 ± 13.5 to 121.4 ± 13.4 μm and
the % of porosity from 73.8 ± 7.3 to 82.8 ± 5.2%.
3.1.2 Water uptake and weight loss. The results of water
uptake (WU) and weight loss (WL) can be seen in Fig. 2. With
respect to WU, all of the studied formulations reached
maximum swelling stability after 1 day of immersion. From
that day to day 30 the percentages of swelling were more or
less constant. H60:40 is the formulation with higher WU, pre-
senting values slightly above 2000%. In contrast, H0:100% is
the system having lower WU, with values reaching 1000%. The
H60:40 formulation showed a higher mass loss (around 45%)
when compared to the other formulations. In contrast,
H0:100% formulations underwent the lowest WL, as the loss
reached an average of 20 to 30% of mass after 30 days.
3.2 Biological in vitro assays
3.2.1 Metabolic activity of immortalized Schwann cells.
The results (Fig. 3A) show a general increase in the metabolic
activity on increasing the amounts of MA-GG in the formu-
lations, regardless of the time point analysed, the highest
values were obtained for H0:100. However, in general, the
metabolic activity values did not increase significantly over
Fig. 2 Percentage of water uptake and weight loss of the developed
GG freeze-dried hydrogels. The graphics present the water uptake and
weight loss values corresponding to all the studied formulations along
the 30 days of study. The evaluations were performed at 37 °C.
Fig. 3 Biocompatibility of GG formulations with immortalized Schwann cells (iSCs) in vitro. (A) Metabolic activity of iSCs seeded on freeze-dried
hydrogel formulations after up to 7 days; determination by Alamar Blue; n = 3. (B) Representative Live/Dead qualitative assay images after direct iSC
seeding on freeze-dried hydrogel formulations after up to 7 days; determination by Calcein AM (green ﬂuorescence) and propidium iodide (red
ﬂuorescence). Scale bars: 200 μm.
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time. The only exception was formulation H0:100%, with a sig-
nificant increase in metabolic activity both from day 1 to 5 and
from day 1 to 7. Indeed, both at 5 and 7 days the metabolic
activity of iSCs seeded onto the H0:100% formulation was sig-
nificantly higher than that obtained from iSCs on H60:40 and
H50:50.
3.2.2 Live/dead viability assay. In Fig. 3B it can be seen
that, in accordance with the metabolic activity quantification,
an increasing number of living cells are present in the formu-
lations with the increase in the amount of methacrylated GG,
from H60:40 to H0:100. As expected, the number of living cells
also increases progressively with time (days in vitro).
Importantly, the number of dead cells is negligible, as
reflected by the presence of very few red-stained spots.
3.3 In vivo studies
A concise summary of all the results presented in the following
paragraphs for the GG filled NGCs can be found in the ESI.†
Wherever appropriate, the reader will be referred to Tables S4,
S5 or S6† that summarize the results of an evaluation per-
formed on samples retrieved 3 weeks, 6 weeks and 12 weeks
after reconstruction, respectively. For the ST studies,
hollow chitosan tubes served as positive controls20 and 4
animals per group were selected for implantation of each NGC
formulation. For LT studies, the autologous nerve graft
(AUTOG) group served as controls and 7 animals were sub-
jected each to implantation of either an NGC formulation or
an AUTOG.
3.3.1 Evaluation of functional motor recovery. Functional
nerve regeneration was only examined during the LT experi-
ment (at 4, 8 and 12 weeks). Here, the recovery observed after
implantation of NGCs filled with diﬀerent freeze-dried GG for-
mulations (n = 7 NGC60:40, n = 7 NGC50:50, n = 5 NGC25:75)
was compared to that observed after implantation of AUTOGs
(n = 7). In the following weeks, however, the number of
animals in the NGC25:75 group was reduced by two in com-
parison with the other groups, because the animals had to be
removed from the study after showing massive autotomy
behaviour. The results of electrodiagnostic measurements are
presented in Table 2. After 4 weeks of implantation there was
no functional recovery. Consequently, the presented results
correspond to 8 and 12 weeks post-implantation. After
8 weeks, only animals from the AUTOG group showed nerve
recovery, represented by CMAPs recorded from the tibialis
anterior (86%) or plantar muscles (43%) upon stimulation of
the reconstructed sciatic nerve. At 12 weeks post-surgery, the
control group (AUTOG) demonstrated an increased degree of
recovery with 100% and 71% evocable CMAPs recorded from
the tibialis anterior and plantar muscles, respectively.
Recovery in animals transplanted with GG-filled NGCs was
less frequent. At that time point, nerve reconstruction with
NGC60:40 did not result in any detectable muscle reinner-
vation. Only two animals from the NGC50:50 (29%) group and
three animals from the NGC25:75 group (60%) displayed evoc-
able CMAPs, which were also recordable only from the more
proximal tibialis anterior muscle. The small number of
animals displaying motor recovery detectable by electrodiag-
nostic procedures did not justify any statistical analysis.
However, as depicted in ESI Fig. S1,† a closer look at the CMAP
amplitude ratios (mVipsilateral/mVcontralateral) revealed that the
quality of regeneration in one animal of the NGC25:75 group
ranged among the values also detected in the AUTOG group
animals.
3.3.2 Macroscopic inspection of nerve implants. Since the
chitosan NGC is transparent, macroscopic inspection of its
content can be performed with the help of a microsurgery
microscope. At 3 weeks post-surgery a tissue bridge connecting
the nerve ends through the hollow NGCs of the control group
were detectable in 4/4 cases, as expected from the positive
control. At the same time, NGCs from the NGC60:40 group did
not contain any visible tissue (0/4), while 1/4 NGC50:50
samples and 2/4 NGC25:75 samples displayed some (nerve)
tissue infiltration of the GG scaﬀolds. ESI Fig. S2† shows
photographs of representative samples harvested at 3 weeks
post-surgery and ESI Table S4† summarizes the results of the
macroscopic inspection of all samples.
At 6 weeks after surgery 3/4 NGCs from the control group
(hollow chitosan NGCs) contained a visible tissue bridge con-
necting the nerve ends, while the last specimen from this
group only contained a hairy connection, as it was not much
thicker than a hair when inspected by the naked eye. Again,
NGCs from the NGC60:40 group did not display visible
ingrowth of nerve tissue into the GG scaﬀolds. However, the
scaﬀolds appeared to be infiltrated by cells. At the same time
1/4 NGC50:50 samples and 3/4 NGC25:75 samples appeared to
contain more organized (nerve) tissue. Residues of GG s could
be clearly identified in the latter two groups as well. It is note-
worthy that some of the samples demonstrated a clear vascu-
larization of the NGC contents. ESI Fig. S3† shows photo-
Table 2 Evaluation of functional motor recovery. This table presents
the percentages, as well as animals per group, with evocable compound
muscle action potentials (CMAPs) recordable from the tibialis anterior
muscle or plantar interosseous muscle. The measurements were per-
formed 4, 6 and 12 weeks after nerve reconstruction surgery. The
varying animal numbers displayed for CMAP recordings from tibialis
anterior and plantar muscles, respectively, are related to eventual tem-
porary suspension of animals from plantar recordings upon the occur-
rence of signs of minimal autotomy
8 weeks 12 weeks (invasive)
Animals/
group Percentage
Animals/
group Percentage
Tibialis anterior muscle
AUTOG 6/7 86% 7/7 100%
NGC60:40 0/7 0% 0/7 0%
NGC50:50 0/7 0% 2/7 29%
NGC25:75 0/5 0% 3/5 60%
Plantar muscle
AUTOG 3/7 43% 5/7 71%
NGC60:40 0/7 0% 0/7 0%
NGC50:50 0/3 0% 0/6 0%
NGC25:75 0/4 0% 0/5 0%
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graphs of representative samples harvested at 6 weeks post-
surgery and ESI Table S5† summarizes the results of the
macroscopic inspection of all samples.
At 12 weeks after surgery, all NGCs contained either resi-
dues of the freeze-dried GG hydrogel material or the same
together with tissue infiltration. NGC contents frequently dis-
played a vascularization by small vessels grown longitudinally
through the NGC. Compact nerve tissue, however, could not be
clearly identified macroscopically. Implants were more closely
inspected for which a content of regenerated nerve tissue
could be expected after positive evaluation with electrodiag-
nostic procedures. This was the case for two samples from the
NGC50:50 group and three samples from the NGC25:75 group.
The NGC50:50 samples indicated from a macroscopic inspec-
tion that the regrown tissue had used the GG scaﬀolds as gui-
dance structures. From the macroscopic inspection of the
NGC25:75 samples it appeared that the regenerated tissue was
more grown around or along the central GG scaﬀold instead of
having the axons using the longitudinal channels within them
as guidance structure. However, these impressions were put
into another perspective after a histological evaluation of the
samples as described below. ESI Fig. S4† shows photographs
of representative samples harvested at 12 weeks post-surgery
and ESI Table S6† summarizes the results of the macroscopic
inspection of all samples.
3.3.3 Micro-computed tomography (micro-CT) evaluation
of the explants. The samples harvested at the end of the LT
study (12 weeks after implantation) were subjected to a micro-
CT evaluation in order to analyse the 3D and 2D dimensions
of the residual GG hydrogel matrices and eventually ingrown
nerve tissue. Fig. 4 illustrates representative findings from the
micro-CT evaluation of the explants, namely the explants’ 3D
and 2D images and the histograms that complement the histo-
logical images plus a correlating histological section after HE
staining. In the AUTOG sample (positive control), the nerve
tissue was clearly visible in the 3D image (enclosed in parafilm
so that the samples would not dry) and corroborated by the
histogram (Fig. 6A). No signs of new tissue formation were
found in the NGC60:40 sample (Fig. 6B). The NGC50:50
sample’s micro-CT images apparently showed some new tissue
formation pointed out by the black arrow (Fig. 6C). In the
NC25:75 sample, the brighter spots (white arrows) correspond
to newly formed tissue, making the histogram more similar to
the autologous graft (Fig. 6D). Despite the fact that NGC̲50:50
samples revealed the presence of some tissue, it did not
appear to be as mature as the tissue detected in AUTOG and
the NC25:75 samples.
3.3.4. Nerve histology for the detection of axonal regener-
ation and immunological reaction. The samples harvested
3 weeks after reconstruction were cut into cross-sections at
certain distances from the proximal nerve end as exemplified
in Fig. 5 (top row). HE and NF200 (data not shown) staining
attested to the findings from the macroscopic evaluation: only
1 of the 4 NGC60:40 samples and 2 of the 4 NGC50:50 samples
presented a certain degree of regrown tissue all along the
conduit. The same was verified for 3 of the 4 NGC25:75
samples. HE representative microscopic pictures can be seen
in Fig. 5, where black arrows point to regenerated tissue in
every cross-section analysed (A, B, C and D). Histological
images show that, regardless of the formulation, GG was still
present inside the conduits (marked by asterisks and stained
Fig. 4 Micro-computed tomography (micro-CT) evaluation of the
explants 12 weeks after surgery and correlation to a corresponding HE
stained histological section. For each sample, diﬀerent characterization
images are displayed in a panel, from left to right: 3D micro-CT recon-
struction image, corresponding histograms concerning three areas of
the conduit (top, middle and bottom), 2D micro-CT reconstructions
(longitudinal sections in vertical and horizontal images and cross section
in the quadratic box image) and histological sections (HE staining) in the
upper left part of each panel. Note that in the case of the NGCs just the
lumen area was selected as a Region of Interest (ROI) for the 3D recon-
struction, thus excluding the chitosan tubes from the analysis. All
samples were covered with paraﬁlm to avoid water evaporation.
(A) Positive control where the autologous nerve graft is visible and
enclosed by paraﬁlm; (B) the representative NGC60:40 sample shows no
sign of cellular or tissue ingrowth in the NGC or the central GG matrix;
(C) the representative NGC50:50 sample shows some tissue inside the
NGC or the GG matrix (indicated by black arrows); (D) the representative
NGC25:75 shows some tissue ingrowth (indicated by white arrows).
Scale bar: 500 μm.
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in soft pink). Most of the residual GG material was detected in
the NGC60:40 group samples. In general, re-growing tissue fol-
lowed the longitudinal channels as guidance structures in
NGC25:75 samples, where tissue regeneration was observed
across the whole conduit. ESI Table 3† summarizes the results
of the histological evaluation of tissue regrowth and axonal
regeneration of all NGC samples harvested 3 weeks after
reconstruction.
The samples explanted 6 and 12 weeks after the reconstruc-
tion were cut longitudinally in order to display the entire
regeneration distance and tissue extension along the conduit.
Representative pictures of such slides can be seen in Fig. 6. In
all samples varying amounts of GG were still visible inside the
NGC (marked by asterisks and stained in light pink). During
analysis of both HE and anti-NF200 staining of sections corres-
ponding to the 6 weeks’ time point (upper row of Fig. 6), the
impressions from the macroscopic evaluation were confirmed.
Fig. 6A, corresponding to the positive control (hollow NGC),
indicates the formation of a complete nerve bridge linking the
two extremes of the lesion. In samples belonging to the
NGC60:40 group, almost no cellular tissue or axons were
detectable in the inner part of the conduit. Instead, NF-200
immunopositive axons were located along the tube wall, avoid-
ing the GG as growth substrate (see an example in Fig. 6B).
The appearance of samples belonging to the NGC50:50 group
was inconsistent. In general, less residual GG was present than
in NGC60:40 samples (see an example in Fig. 6C) as 3/4 of the
NGC25:75 presented an organized and almost intact tissue
cable that almost extends to the distal nerve end. In these
3 encouraging samples, anti-NF200 stained regenerating axons
(green fluorescence) were elongating from proximal to distal
through the NGCs. An example of the NGC25:75 sample is
shown in Fig. 6D. ESI Table 4† summarizes the results of the
histological evaluation of tissue regrowth and axonal regener-
ation of all NGC samples harvested 6 weeks after
reconstruction.
Histological findings corresponding to 12 weeks after nerve
reconstruction (lower row of Fig. 6) match the ones from pre-
vious time points. The positive control in this case, an auto-
transplant, displayed a thick and complete nerve bridge
between the original nerve ends that is mainly composed of
NF200 immunopositive axons (Fig. 6A). In the
NGC60:40 group the formation of new nerve tissue was scarce,
and it showed pronounced fragmentation, indicating the com-
plete absence of linearity (Fig. 6B). Samples from NGC50:50
displayed nerve trunk fragments irregularly found all along the
nerve gap. This indicates the absence of a continuous nerve
bridge with a consistent linear trajectory. Even in the samples
that presented positive results in the electrodiagnostic record-
ings, the regenerated axons were not found to be aligned along
Fig. 5 Representative photomicrographs of the studied formulations after haematoxylin–eosin (HE) staining. Schematic representation of the
cross-section positioning (top row, the example NGC is placed on scale paper with 1 mm intersections). Rows 2–4: HE stained cross-sections
corresponding to chitosan hollow NGCs (positive control for the ST study) and NGCs ﬁlled with diﬀerent GG freeze-dried formulations (NGC60:40,
NGC50:50, NGC25:75) explanted 3 weeks after reconstruction. Black arrows point to regenerated tissue in the respective cross-sections. Asterisks
are placed where residual GG is visible inside the NGCs. Scale bars: 200 μm.
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the longitudinal histological sections analysed (Fig. 6C).
Almost all samples belonging to NGC25:75, namely the ones
that presented positive results in the electrodiagnostic evalu-
ation, display a thin but continuous nerve cable nearly con-
necting the two nerve ends along the histological sections ana-
lysed. Immunohistochemistry of these samples shows oriented
axons along the conduit, invading the GG, which serves as a
guiding cue, thus diﬀering from the previous case. ESI
Table S6† summarizes the results of the histological evaluation
of tissue regrowth and axonal regeneration of all NGC samples
harvested 12 weeks after reconstruction.
3.3.5. Nerve histology for the detection of neovasculariza-
tion. Neo-vascularization was qualitatively evaluated by posi-
tive expression of two endothelial markers: CD31 (expressed
on platelet and endothelial cell adhesion molecules, detected
by green fluorescence) and CD34 (expressed on hematopoietic
progenitor cells and the small vessel endothelium, detected in
red fluorescence). Samples were collected from both, the ST
and the LT, studies. The results of the immunohistochemical
analysis show both blood vessel growth and blood cells pro-
liferation. The presence of these vascular components is incre-
mented as the amount of MA-GG in the formulations
increases. Accordingly, NGC50:50 and NGC25:75 samples
present an increasing neovascularization and it was percepti-
ble that newly formed blood vessels accompany the newly
formed tissue throughout the conduit. This tendency was veri-
fied at all the studied time points (see Fig. 7 and ESI Tables
S3–S5†).
3.3.6. Nerve morphometry of distal nerve segments. Nerve
morphometry was performed on samples harvested in the LT
study. For these analyses, only distal nerve segments originat-
ing from reconstructed nerves that have demonstrated muscle
re-innervation during the final electrodiagnostic measure-
ments were considered. More specifically, samples from the
NGC50:50 and NGC25:75 groups were assessed, besides
samples from the AUTOG positive control group (see
Table S3†). Further control values were obtained from unin-
jured contralateral nerve segments. Although not significantly,
it is obvious from Table S3† and Fig. 8 that the total number
and density of NGC50:50 and NGC25:75 axons were decreased
with respect to the values obtained from AUTOGs and
increased with respect to healthy nerve values. However,
AUTOGs, NGC50:50s, and NGC25:75 axon and fiber diameters,
as well as myelin thickness, were reduced in distal segments
from reconstructed nerves when compared to healthy nerves.
Significantly reduced values were detected for the axon dia-
meter, fibre diameter and myelin thickness between
healthy and NGC25:75 distal nerve segments. Fig. 8 illustrates
the previous quantitative results. It shows high resolution
images of representative nerve semithin sections, stained
Fig. 6 Representative photomicrographs of histologically stained NGCs with GG ﬁllings 6 and 12 weeks after reconstruction. Longitudinal sections
for each sample after HE staining can be seen at left and the respective immunohistochemistry staining for NF200, ED1 and DAPI at right. (A) Positive
control (hollow conduit at 6 weeks (ST study) and autologous nerve graft (LT study) at 12 weeks); (B) NGC60:40 sample; (C) NGC50:50;
(D) NGC25:75. Proximal nerve end is on the top and distal nerve end is on the bottom. Asterisks mark the visible GG in light pink. Scale bars: 500 μm.
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with Toluidine blue, from a healthy sciatic nerve (A), an
AUTOG (B), an NGC50:50 conduit (C + D) and an NGC25:75
conduit (E + F).
4. Discussion
Experimental approaches for developing novel nerve guidance
conduits (NGCs) lay an emerging focus on the creation of a
three-dimensional endoneurial structure (resembling the
Bands of Büngner).34 The internal structures of luminal fillers
of otherwise hollow NGCs should contribute to the regener-
ation process in diﬀerent ways: (i) increase the intraluminal
surface area, (ii) serve as supportive platforms to facilitate the
extension of the regenerating axons, (iii) promote endogenous
Schwann cell function, and (iv) eventually act as a drug delivery
vehicle of pro-regenerative substances.34,35 However, it should
be kept in mind that the intraluminal structures may also
negatively influence the regeneration process, for instance, by
compromising the luminal permeability and penetrability or
by aﬀecting the NGC flexibility.36 Gellan Gum (GG) was the
material chosen as a luminal filler in this peripheral nerve
repair (PNR) oriented study because of its biocompatibility,
adequate physical properties, simply tunable features37 and
the fact that it has been largely explored within our group, in
the context of other regenerative areas, with encouraging
results.38,39 The NGC shielding tube is made of chitosan with
Fig. 7 Detection of neovascularization in the implanted formulations. Representative photomicrographs of immunohistologically stained sections
corresponding to the studied formulations. Stains were performed for the detection of CD31 (green) and CD34 (red) after 3, 6 and 12 weeks post-
reconstruction. Photomicrographs correspond to the central zone of the conduits. (A) Positive control (at 3 and 6 weeks is a hollow NGC and at 12
weeks is an ANG); (B) NGC60:40; (C) NGC50:50; (D) NGC25:75. Scale bars: 50 μm.
Fig. 8 Representative photomicrographs of myelinated axons visual-
ized in distal peripheral nerve segments 12 weeks after reconstruction.
High resolution images of representative semithin sections, stained with
Toluidine blue, of nerve samples from (A) a healthy sciatic nerve and
(B) that regenerated through an ANG; (C + D) NGC50:50 conduit, and
(E + F) NGC25:75 conduit. Scale bars: 20 μm.
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approximately 5% degree of acetylation, which has already
proved its PNR supporting properties.9,20,40
The rationale behind this experimental work is based on
the fact that the hollow chitosan nerve guides approved as
Reaxon® Nerve Guides fail to reconstruct peripheral nerve
defects larger than 2.6 cm. Indeed, it is very diﬃcult to bridge
larger defects with bioartificial nerve grafts without the help of
any type of cue, either physical or chemical, like the use of
luminal fillers or growth factors, respectively.41 In fact, allo-
grafts are the best option for longer gaps since they naturally
provide the needed cues, like the native extracellular matrix
present in the grafts but access to it is extremely diﬃcult.42 A
luminal filler providing a valuable milieu for invading
Schwann cells, good axonal guidance and induction of vascu-
larization is suggested to lead to the development of such an
implant. The GG freeze-dried hydrogel was chosen as a
luminal filler in this study because of the ability to easily tune
GG formulations and thereby influence its polymeric behav-
iour. Accordingly, diﬀerent HA-GG : MA-GG blends gave rise to
the diverse luminal fillers studied.43 The evaluation of their
characteristics was performed in a 10 mm sciatic nerve defect
in order to select the most promising as a luminal filler for
NGCs for future studies in longer gaps.
The first part of the study was dedicated to the production,
physicochemical and in vitro testing of HA-GG :MA-GG freeze-
dried hydrogels. The second part focused on the in vivo evalu-
ation of diverse regeneration-associated parameters after the
implantation of the developed NGCs.
A major constraint of traditional hydrogels as cell-instruc-
tive biomaterials for tissue engineering applications concerns
the absence of cell adhesion motifs. For that reason, an
intermediate step of freeze-drying was included in the process
to obtain the final materials. This process transforms the
specific spatial disposition of the hydrogel network. When the
dry matrices are rehydrated with a cell suspension, cells
become entrapped and are able to adhere and proliferate.
This methodology oﬀers the possibility of producing cell sup-
porting matrices oﬀ-the-shelf that can be stored and quickly
used.
Increasing attention is also being paid to the micro- and
nanostructure of tissue engineering scaﬀolds for PNR.35
Indeed, diﬀerent strategies have been explored in this respect,
i.e. the use of aligned fibres,44 channels,45 patterned surfaces46
or electrical and magnetic fields.47 In this respect, longitudinal
channels were physically induced within our hydrogels by
punching with a stainless-steel device.
SEM analysis demonstrated the micro-structure obtained in
the final networks, where the freeze-drying induced porosity
contrasts with the punched aligned porosity.
X-ray micro-computed tomography provides insight into
how the GG scaﬀolds are oriented within the NGC. This tech-
nique captures images with spatial resolution in the micron
domain, using X-ray beams to probe the interiors of opaque
solid objects. Large pores and high % of porosity lead to
minor trabecular thickness, which is translated into fragile
and brittle systems in the dry state. Comparing the results,
there seems to be no relationship between the mean pore size
or the % of porosity and the amount of HA-GG or MA-GG in
the formulations.
These results were within the expected range, as we envi-
sioned a highly porous and interconnected matrix inside the
chitosan conduit, which would allow the growth of regenerat-
ing fibres, as well as guide them. Indeed, the method of pro-
duction, freezing at −80 °C and subsequent freeze-drying, was
selected because it allows great pores to be formed.21
However, despite the identically rigorous processing of
freeze-dried hydrogels and NGCs, higher mean pore sizes and
trabecular thickness were obtained in the second case.
This indicates that the protector layer of the chitosan tube influ-
ences the formation of water crystals, probably by lowering the
speed of freezing, ultimately altering the microstructure of the
GG network inside the conduit. As a result, fewer pores are
created, with reduced % of porosity and increased trabecular
thickness. This eﬀect can be also appreciated in the SEM
images.
Concerning water uptake (WU), this parameter is related to
the exchange of metabolic products and nutrients. Meanwhile,
the weight loss (WL) is a parameter related to the bio-
degradation of the biomaterial. An optimized device for peri-
pheral nerve reconstruction should remain intact until a
proper invasion of repair Schwann cells occur, as these cells,
together with invading perineurial cells, build the forefront of
a regenerating nerve,48 and then progressively degrade as the
re-growing axons occupy new space.49 Our in vitro results
confirm that the formulations containing more MA-GG suﬀer
from less swelling and degradation over time, as higher WU
and WL were verified in H60:40, while the lowest values
occurred for H0:100. On the one hand, this is probably
because of the tighter matrix granted by the MA-GG when com-
pared to native GG. In addition, methacrylate groups are
hydrophobic in nature, thus impairing the interaction with
water molecules.50 On the other hand, higher percentages of
HA-GG have been linked to faster degradation, due to the acyl
group in its structure, which interferes with the gelling
process. The resultant gels are weaker. Our results indicate
that a relationship exists between the swelling ability and the
degradation of the freeze-dried hydrogel materials. The formu-
lations that take up more water are the ones that suﬀer more
hydrolysis. This leads to the hypothesis that as water is taken
up, it starts to break the trabeculae in the formulation
microstructure.
Since to our knowledge GG systems have not been pre-
viously explored for PNR purposes, an immortalized Schwann
cell line was used to evaluate the eﬀect of the studied formu-
lations on the performance of peripheral glial cells. The results
indicate that a higher portion of MA-GG in the formulations is
related to higher cell metabolic activity. This tendency has been
previously observed for diverse cell types,38,51 and is probably
related to the stability and micro-structure of the matrices that
MA-GG forms. An increased metabolic activity of invading
Schwann cells is expected to be beneficial for the peripheral
nerve regeneration process in vivo. In fact, nerve reconstruction
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with formulations containing larger amounts of MA-GG, such
as NGC25:75, resulted in better functional recovery than recon-
struction with the other GG containing NGCs.
Summarizing the characterization results up to this point,
the formulations containing larger amounts of HA-GG are
likely to have a higher swelling rate, which is also likely to be
accompanied by a faster degradation. Meanwhile, formu-
lations with larger amounts of MA-GG oﬀer the advantage of
having a more positive influence over the cells in contact
with them. In vivo experiments were designed in order to inves-
tigate how these characteristics balance each other once the
formulations have been implanted into a peripheral nerve
defect. Although the H0:100 formulation induced the highest
cell metabolic activity, its low degradation rate seems inap-
propriate for PNR purposes. Accordingly, it was excluded from
the in vivo tests in order to avoid unnecessary animal
sacrifices.
In vivo results did not match the degradation rates of the
isolated GG formulations in vitro. The in vivo tests showed that
only small amounts of GG hydrogel residues were present in
NGC25:75 (higher amounts of MA-GG) samples 6 and 12
weeks after nerve reconstruction. Vice versa, formulations con-
taining larger amounts of HA-GG (NGC60:40) displayed larger
residual amounts of non-degraded GG, which seemingly
impaired regenerative tissue growth. Although isolated HA-GG
formulations have higher degradation rate in vitro, certainly by
hydrolysis mechanisms, it seems that other biological para-
meters influence the in vivo biodegradation of the studied for-
mulations (i.e. specific enzymes such as amylase and lysozyme,
cellular interaction or fluid infiltration),50 leading to a faster
clearance as the amount of MA-GG increases. The specific GG
degradation mechanisms in vivo have not yet been identified
yet.24 WU also played an important role in the in vivo out-
comes, as an excessive WU of the formulations containing
increasing quantities of HA-GG has likely led to lumen-occlu-
sion phenomena. The complete failure of nerve regeneration
through NGC60:40 grafts could be a consequence of this
phenomenon, allied to lower peripheral glial cell adhesion
and axonal ingrowth. Following nerve transection, the process
of regeneration is largely dependent on the activity of non-
neuronal cells, such as macrophages or Schwann cells.52 In
fact, macrophages that are attracted to the injury site secrete
substances that increase Schwann cell migration.53 Beyond
that, invading macrophages play a key role in eliminating both
myelin and axonal debris, as well as in releasing a large
number of axonal regeneration-related substances, including
extracellular matrix (ECM) proteins, growth factors, cytokines
and chemokines.53 Consequently, the presence of such
immune cells in the distal nerve segments following injury is
important for the remodelling of the nerve. Nevertheless, an
excessive and persistent amount of activated macrophages
induced by the transplanted nerve guide material may lead to
a progressive inflammatory response, which will have a detri-
mental eﬀect on regeneration.53 Both after 3, 6 and 12 weeks,
NGC25:75 demonstrated a presence of activated ED1-immuno-
positive macrophages qualitatively comparable to that in the
positive control. These macrophages probably contributed to
myelin and axonal clearance, a process that may be prolonged
during weeks. In addition, macrophages were detected all
along the lumen of NGC60:40 and NGC50:50 after 6 and
12 weeks of implantation. The fact that the formulations with
larger HA-GG amount present more macrophages might
suggest that this polymer is recognized as a foreign body by
the host organism. Despite the good biocompatibility results
shown by GG in other regenerative applications,54 a foreign
body reaction might originate due to the fact that these formu-
lations were not degrading during the observation time. This
finding points to the need of a faster degrading luminal filler
material. Also, the authors hypothesize that the same formu-
lations with larger HA-GG amount present great values of WU
that impaired regeneration and that may also arouse some
type of vigilante response by the host organism.55
The vascular net supplying peripheral nerves is very
complex.56 Furthermore, it is long known that angiogenesis is a
crucial factor for a successful peripheral nerve regeneration
across a critical length nerve gap and required for cell survival.57
CD31 (PECAM-1; platelet/endothelial cell adhesion molecule-1)
is a single chain type-1 transmembrane protein present in endo-
thelial cells, which plays a key role in the interaction with adja-
cent CD34 (a single-chain transmembrane glycoprotein) expres-
sing haematopoietic precursor cells or capillary endothelial
cells. Both proteins are related to microvasculature formation.58
After qualitative analysis, it seems that regardless of the GG for-
mulation implanted within the NGCs, there was angiogenesis
taking place. However, the presence of blood vessels (as well as
the presence of erythrocytes within capillaries) seems to
increase as the amount of MA-GG also increases within the for-
mulations. This improved neoangiogenesis verified in
NGC50:50 and NGC27:75 at all time points studied could have
positively influenced the extent of functional recovery.
Interestingly, after 3 and 6 weeks, CD31 positive endothelial
cells were not detected in any of the analysed sections, in con-
trast to CD34 that marked both blood vessels and red blood
cells. However, by 12 weeks, both markers have been perceived,
with CD34 marking mainly the endothelial cells in the walls of
the newly generated blood vessels and CD31 identifying red
blood cells. One possible explanation for this is that CD31 only
identifies diﬀerentiated and mature cells, while CD34 already
detects precursors of endothelial cells or not completely diﬀer-
entiated cells.59
The previously described micro-CT methodology is also a
popular method to evaluate tissue engineering constructs,60
human tissues61 and animal tissues.62 In a typical micro-CT
image, relatively higher density structures appear brighter than
structures with lower density. Soft tissues usually have a uniform
density, and their internal structure cannot be discriminated
with a conventional micro-CT method.63 During the analysis of
the explanted formulations, water, GG, and regenerated nerve
tissue could not be discriminated properly in the wet explants
since the densities of the soaked polymer and soft-tissue like
nervous tissue are identical. The results of the current study
indicate that NGC25:75 has better biological performance than
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others, however, still not as good as the autologous graft. This
information could not be retrieved from the 3D images recon-
structions, but from the 2D cross and longitudinal sections and
the histograms related to these images, in which density diﬀer-
ences were detected pointing to the previous aﬃrmation.
The initial macroscopic inspection of the explants after the
in vivo observation time, matched the histological findings,
such as the lumen-blocking properties of NGC60:40 and the
pronounced induction of vascularization by NGC25:75. This, in
turn, finds functional correlation with the results obtained from
electrophysiological measurements, micro-CT analysis and
nerve morphometry assessments in the distal nerve segments
after 12 weeks post-surgery. Overall, the regeneration promoting
properties of chitosan NGCs filled with the freeze-dried hydro-
gel GG scaﬀolds is significantly reduced in comparison to
hollow chitosan NGCs for which in the same model in 69% of
animals evocable CMAP signals were recorded from the tibialis
anterior muscle 12 weeks after nerve reconstruction.20 Muscle
reinnervation detectable by electrodiagnostic procedures was,
however, still found in some animals investigated throughout
the current study. Nerve reconstruction with NGC60:40 comple-
tely prevented proper muscle reinnervation, while occurred to
an increasing percentage in the NGC50:50 group and in the
NGC25:75 group. Reinnervation of distal plantar interosseous
muscles did, in the current study, only occur in the AUTOG
group and was demonstrated, although to a lesser extent, also
after implantation of hollow chitosan NGCs.20 Morphometric
analysis performed on nerve cross sections obtained distal to
the grafts that resulted in functional recovery, confirmed the
presence of regenerated myelinated axons. The fact that the
overall results of the nerve morphometry indicate NGC50:50 as
the eventually most promising formulation might be mislead-
ing, since despite two animals out of seven showed outstanding
functional recovery, the remaining five showed no functional
recovery at all. Consequently, it is probable that these outstand-
ing results were due to any inter-individual variability between
the groups of rats.
All together, these findings indicate that filling the lumen
of chitosan NGCs with freeze-dried hydrogel GG scaﬀolds
could not increase their peripheral nerve regeneration
promoting properties, with results that do not outperform the
positive controls used in both ST and LT studies (hollow chito-
san tube and AUTOG, respectively). The concept of providing
additional guidance structures inside the lumen of the
NGCs is however still promising.9 Indeed, the NGC25:75
implants showed a better performance than 5% degree of
acetylation chitosan conduits containing NVR-Gel (composed
of high molecular weight hyaluronic acid and laminin) as
luminal filler. This study was performed by some of the
authors of the present work, and proved that the previously
indicated non-freeze dried hydrogels dramatically impaired
nerve regeneration.21 However, both of these studies demon-
strate that a luminal filler such as an hydrogel or hydrogel-like
structure present in the lumen might have detrimental eﬀects
in terms of nerve regeneration, since some obstruction is
observed.
However, these results concerning the NGC25:75 highlight
the potential of the GG presented during this experimental
work, indicating the interest in continuing our research in this
direction, further improving our NGC systems with methacry-
lated biomaterial.
5. Conclusions
This work demonstrates for the first time the innovative use of
gellan gum freeze-dried hydrogels as luminal fillers for nerve
guidance conduits intended for peripheral nerve reconstruc-
tion. The biomaterials have been evaluated in vitro before
in vivo trials were initiated to define their short and long term
potential to support peripheral nerve regeneration through
chitosan nerve guides. The outcome of our studies demon-
strates that the use of GG fillers did not result in improved
nerve regeneration and that our system still has to be opti-
mized. So far, the presence of such biomaterial in the lumen
of the chitosan tubes might have negative eﬀects in terms of
nerve regeneration. The best results, however, have been
achieved in the presence of larger amounts of MA-GG in the
blending systems. The methacrylated material better sup-
ported axonal regeneration and increased vascularization, ulti-
mately resulting in a certain degree of muscle re-innervation.
Future attempts need to be focused on MA-GG formulations or
peptide-modified GG for luminal fillers that are presented
with lower concentrations of polymer or supplemented with
supporting cells and/or regeneration promoting cues.
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